Diabetes decisions — 2025

The appeal for service connection for sleep apnea was dismissed due to it not being adjudicated by the AOJ within a year of the Notice of Disagreement.

The claim for service connection for diabetes mellitus was dismissed because the Veteran has already been granted service connection for diabetes.

The Board granted service connection for headaches as secondary to tinnitus and right ankle sprain, but denied an earlier effective date and a higher rating for left eye retinopathy associated with diabetes mellitus type II.

The Board granted service connection for diabetes and a bilateral foot disability, to include neuropathy, based on the evidence showing that these conditions manifested within the one-year presumptive period following the Veteran's separation from active duty.

The Board granted service connection for diabetes mellitus type 2 as it was proximately due to the Veteran's service-connected hypertension and ischemic heart disease (IHD) disabilities.

The Board granted an initial disability rating of 40 percent for service-connected diabetes mellitus type II, as the evidence supports that the Veteran's condition requires insulin, a restricted diet, and regulation of activities.

The Board remands the claims for service connection for diabetes mellitus and myelodysplastic syndrome to obtain further evidence regarding the Veteran's alleged exposure to herbicides.

The Board denied the veteran's claims for increased ratings and TDIU, as the evidence did not support a higher rating or unemployability due to service-connected disabilities.

The Board granted service connection for diabetes, type II and peripheral neuropathy of the feet as secondary to that condition. The claims for hypertension, heart disease, colon cancer, and skin cancer were remanded.

The Board denied the claims for service connection for a brain tumor and diabetes mellitus, finding no evidence of a causal relationship between these conditions and the Veteran's military service or any service-connected disabilities.

The Veteran was granted a 60 percent disability rating for hypothyroidism from July 8, 2016, to August 26, 2020, and a 100 percent disability rating from August 26, 2020. Special monthly compensation at the housebound rate was also granted from that date.

The Veteran's service connection for diabetes mellitus, type II was granted due to exposure to herbicides during his service in Panama. Other claims were remanded.

The Board granted service connection for obstructive sleep apnea (OSA) but dismissed the appeals for pre-diabetes, headaches, high blood pressure, and PTSD.

The Board remands the claims for service connection for hypertension and diabetes mellitus due to inadequate medical opinions regarding their etiology, including exposure to toxins during service.

The Board granted service connection for sarcoidosis of the lung 4th stage, skin, head and remanded the claims for diabetes mellitus, type II, hypertension, joint pain (all) (also claimed as right hip), and peripheral neuropathy (also claimed as lower extremities).

The Board denied service connection for various disabilities, including right hip, left knee, right knee, diabetes mellitus, erectile dysfunction, and asthma. The initial rating for asthma was also denied.

The Board granted service connection for coronary artery disease, denied an initial rating in excess of 20 percent for diabetes mellitus type II, and dismissed the claim for service connection for erectile dysfunction, with or without penile deformity.

The Board denied ratings in excess of the current levels for diabetes mellitus, bilateral hearing loss, and otitis media; granted a separate 30 percent rating for vertigo; and granted special monthly compensation based on the need for aid and attendance.

The Board remands the claims for service connection for sleep apnea, prostate cancer, and diabetes mellitus type II due to an incomplete review of potential Agent Orange exposure during the Veteran's service in Korea.

The Board denied an initial rating in excess of 20 percent for diabetes mellitus, type II and granted service connection for pseudophakia as secondary to the Veteran's service-connected diabetes mellitus, type II. The claim for steroid induced chronic kidney disease was dismissed.